Atlas Trials

Evaluation of the Change in PSMA Expression in Prostate Cancer in Response to Hormonal Therapy

Clinical trial NCT05919329 · RECRUITING

Trial details

NCT number
NCT05919329
Sponsor
OHSU Knight Cancer Institute
Status
RECRUITING
Phase
Phase 4
Study type
INTERVENTIONAL
Castration Resistant Prostate CancerCastration Sensitive Prostate CancerProstate Adenocarcinoma
Start date
2024-06-25
Primary completion
2028-09-01
Enrollment
80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.